{"id":"mometasone-furoate-mf","safety":{"commonSideEffects":[{"rate":null,"effect":"Local skin irritation or burning"},{"rate":null,"effect":"Pruritus"},{"rate":null,"effect":"Skin atrophy (with prolonged use)"},{"rate":null,"effect":"Headache (nasal formulation)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Mometasone furoate is a synthetic glucocorticoid that exerts anti-inflammatory effects through glucocorticoid receptor activation, leading to reduced production of inflammatory mediators, decreased immune cell infiltration, and suppression of local inflammatory cascades. It is formulated for topical application to skin or nasal mucosa, providing localized therapeutic effects with minimal systemic absorption.","oneSentence":"Mometasone furoate is a topical corticosteroid that suppresses local inflammatory and immune responses by binding to glucocorticoid receptors.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:22:07.372Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses"},{"name":"Allergic rhinitis (nasal formulation)"}]},"trialDetails":[{"nctId":"NCT02892344","phase":"PHASE3","title":"Study of QMF149 (150/80 µg) Compared With MF Twisthaler® (200 µg) in Patients With Asthma","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2017-01-16","conditions":"Mild Asthma","enrollment":802},{"nctId":"NCT07286201","phase":"NA","title":"Evaluation of the Safety and Performance of a Bioresorbable Nasal Dressing Containing Mometasone Furoate (MF)","status":"NOT_YET_RECRUITING","sponsor":"Polyganics BV","startDate":"2026-01","conditions":"Chronic Rhinosinusitis (CRS), Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps","enrollment":110},{"nctId":"NCT03705793","phase":"PHASE4","title":"Effectiveness of Mometasone Nasal Irrigation for Chronic Rhinosinusitis","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2019-01-01","conditions":"Chronic Rhinosinusitis (Diagnosis), Allergic Rhinosinusitis, Chronic Eosinophilic Rhinosinusitis","enrollment":53},{"nctId":"NCT00779740","phase":"PHASE3","title":"Equivalency Study of Two Formulations of Mometasone Furoate Nasal Spray (Study P04419)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-02-01","conditions":"Rhinitis, Allergic, Perennial","enrollment":102},{"nctId":"NCT00835094","phase":"PHASE4","title":"A Randomized Trial Assessing Once Daily Administration of Mometasone Furoate DPI in Asthmatics (Study P02177)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-10-01","conditions":"Asthma","enrollment":216},{"nctId":"NCT00817817","phase":"PHASE3","title":"A Study to Determine the Efficacy and Safety of Two Mometasone Dry Powder Inhalers in the Treatment of Asthma (Study P02524)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-10-01","conditions":"Asthma","enrollment":93},{"nctId":"NCT01502371","phase":"PHASE2","title":"A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2012-01-25","conditions":"Asthma","enrollment":583},{"nctId":"NCT01135134","phase":"PHASE3","title":"Multicenter, Double-blind, Randomized, Placebo-controlled Study of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06332)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2010-06","conditions":"Rhinitis, Allergic, Perennial","enrollment":333},{"nctId":"NCT01566149","phase":"PHASE3","title":"Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2012-03","conditions":"Asthma","enrollment":49},{"nctId":"NCT01471340","phase":"PHASE4","title":"A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2012-01-09","conditions":"Asthma","enrollment":11744},{"nctId":"NCT00521599","phase":"PHASE4","title":"A Study of the Equivalent Effectiveness of 400 mcg Mometasone Furoate Using Two Different Dry Powder Inhalers in Moderate Asthmatics (Study P04828)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-05","conditions":"Asthma","enrollment":672},{"nctId":"NCT01258803","phase":"PHASE2","title":"A Study of the Bronchodilator Effect of Formoterol Fumarate Used in Combination With Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P06476 AM2)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2010-12","conditions":"Asthma","enrollment":92},{"nctId":"NCT00383721","phase":"PHASE3","title":"Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in Chronic Obstructive Pulmonary Disease (COPD) (Study P04230AM4)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-09","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":1196},{"nctId":"NCT00394355","phase":"PHASE4","title":"Effects of Mometasone Furoate Dry Powder Inhaler, Fluticasone Propionate, and Montelukast on Bone Mineral Density in Asthmatics (Study P03418)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-09","conditions":"Asthma","enrollment":566},{"nctId":"NCT00442117","phase":"PHASE3","title":"A Comparison of Mometasone Furoate DPI Versus Budesonide DPI in Budesonide DPI in Asthmatics (Study P04880)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-06","conditions":"Asthma","enrollment":180},{"nctId":"NCT00383240","phase":"PHASE3","title":"Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04334AM1)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-09","conditions":"Asthma","enrollment":781},{"nctId":"NCT00383435","phase":"PHASE3","title":"Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in COPD (Study P04229AM4)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-10","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":1055},{"nctId":"NCT00424008","phase":"PHASE3","title":"Study of Inhaled Glucocorticosteroids/Long-Acting Bronchodilator Drugs in Subjects With Asthma That Have Been Taking Inhaled Glucocorticosteroids (Study P04705AM1)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-04","conditions":"Asthma","enrollment":722},{"nctId":"NCT00604500","phase":"PHASE3","title":"A Patient Handling Study of Mometasone Furoate/Formortoral Fumarate (MF/F) Metered Dose Inhaler (MDI) With an Integrated Dose Counter in Adolescent and Adult Subjects With Asthma or Chronic Obstructive Pulmonary Disease (Study P04703AM1)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-03-01","conditions":"Asthma, COPD","enrollment":272},{"nctId":"NCT00381485","phase":"PHASE3","title":"Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04431AM2)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-07-01","conditions":"Asthma","enrollment":834},{"nctId":"NCT00379288","phase":"PHASE3","title":"Study of Mometasone Furoate/Formoterol Combination and Fluticasone/Salmeterol in Persistent Asthmatics Previously Treated With Inhaled Glucocorticosteroids (P04139)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-06","conditions":"Asthma","enrollment":404},{"nctId":"NCT00383552","phase":"PHASE3","title":"Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04073AM1)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-09","conditions":"Asthma","enrollment":746},{"nctId":"NCT02741271","phase":"PHASE3","title":"Study of Efficacy and Long-Term Safety of Mometasone Furoate in Combination With Formoterol Fumarate Versus Mometasone Furoate in Children (5 to 11 Years of Age) With Persistent Asthma (MK-0887A-087)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2016-05-11","conditions":"Asthma","enrollment":181},{"nctId":"NCT00635882","phase":"PHASE2","title":"Asthma Study Comparing Anti-Inflammatory Effects of 3 Doses of Mometasone Furoate/Formoterol Fumarate and Medium Dose Mometasone Furoate (Study P05122 AM1)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-02","conditions":"Asthma, Airway Inflammation","enrollment":93},{"nctId":"NCT04656223","phase":"","title":"Digital Adherence Monitoring of Inhalative Therapy in Real- Life Conditions","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2020-12-17","conditions":"Asthma","enrollment":434},{"nctId":"NCT04589663","phase":"PHASE2","title":"Study to Compare the Pharmacokinetics of Mometasone Furoate Alone and in Combination With Indacaterol in Patients ≥ 6 to < 12 Years Old With Asthma","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2021-06-07","conditions":"Asthma","enrollment":24},{"nctId":"NCT05120986","phase":"","title":"An Observational Prospective Study to Characterize Patients Initiating Enerzair® Breezhaler®, With or Without Sensor, as a Maintenance Treatment for Asthma","status":"WITHDRAWN","sponsor":"Novartis Pharmaceuticals","startDate":"2022-02-15","conditions":"Asthma","enrollment":""},{"nctId":"NCT01615874","phase":"PHASE2","title":"Study of the Effect of Mometasone Furoate/Formoterol (MF/F), Montelukast and Beclomethasone Dipropionate (BDP) on Plasma Cortisol Levels of Children 5-11 Years Old With Persistent Asthma (P05574)","status":"WITHDRAWN","sponsor":"Organon and Co","startDate":"2013-01","conditions":"Asthma","enrollment":""},{"nctId":"NCT01026870","phase":"PHASE3","title":"Efficacy and Safety of Mometasone Furoate for Persistent Asthma Previously Treated With Low-Dose Inhaled Glucocorticosteroids (ICS) (Study P06115)","status":"WITHDRAWN","sponsor":"Organon and Co","startDate":"2012-06","conditions":"Asthma","enrollment":""},{"nctId":"NCT03855189","phase":"PHASE3","title":"Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"1993-08-23","conditions":"Seasonal Allergic Rhinitis","enrollment":345},{"nctId":"NCT00783224","phase":"PHASE3","title":"A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-09","conditions":"Perennial Allergic Rhinitis","enrollment":351},{"nctId":"NCT03401229","phase":"PHASE3","title":"Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal Polyposis","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2018-01-15","conditions":"Nasal Polyposis","enrollment":413},{"nctId":"NCT03085797","phase":"PHASE3","title":"Effect of Mepolizumab in Severe Bilateral Nasal Polyps","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2017-05-25","conditions":"Nasal Polyps","enrollment":414},{"nctId":"NCT02554786","phase":"PHASE3","title":"A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With Asthma","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2015-12-29","conditions":"Asthma","enrollment":2216},{"nctId":"NCT03358329","phase":"PHASE3","title":"Safety Evaluation of Repeat Placement of the S8 Sinus Implant in Chronic Sinusitis Patients With Nasal Polyps (ENCORE)","status":"COMPLETED","sponsor":"Intersect ENT","startDate":"2017-11-13","conditions":"Chronic Sinusitis, Nasal Polyposis","enrollment":50},{"nctId":"NCT02397915","phase":"PHASE4","title":"Patient Preference Study of Fluticasone Furoate and Mometasone Furoate Nasal Sprays","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-03-26","conditions":"Rhinitis, Allergic, Perennial and Seasonal","enrollment":300},{"nctId":"NCT01199757","phase":"","title":"A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on Key Health Outcome Measures","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-07-10","conditions":"Rhinitis, Allergic, Perennial","enrollment":540},{"nctId":"NCT02495064","phase":"PHASE4","title":"Mometasone Furoate Cream Reduces Acute Radiation Dermatitis in Head and Neck Squamous Cell Carcinomas' Patients","status":"UNKNOWN","sponsor":"Yao Liao","startDate":"2015-01","conditions":"Early Radiation Dermatitis","enrollment":160},{"nctId":"NCT01555151","phase":"PHASE2","title":"Safety and Efficacy of Mometasone Furoate Delivered Via Concept1 Device or Twisthaler® Device in Adult and Adolescent Patients With Persistent Asthma","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2012-07","conditions":"Asthma","enrollment":739}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":203,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["SCH 032088","MK-0887","Nasonex®"],"phase":"phase_3","status":"active","brandName":"Mometasone Furoate (MF)","genericName":"Mometasone Furoate (MF)","companyName":"Organon and Co","companyId":"organon-and-co","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Mometasone furoate is a topical corticosteroid that suppresses local inflammatory and immune responses by binding to glucocorticoid receptors. Used for Inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, Allergic rhinitis (nasal formulation).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}